What is Diovan?
Diovan is a prescription drug used to treat the symptoms of high blood pressure (hypertension), heart failure, and to prevent death after a heart attack. The medication belongs to a class of drugs known as angiotensin receptor blockers (ARBs) that work by blocking receptors that the hormone acts on, specifically AT1 receptors, which are found in the heart, blood vessels, and kidneys.
Blocking the action of angiotensin II helps to lower blood pressure and prevent damage to the heart and kidneys. Diovan is made by Novartis, and was approved by the U.S. Food and Drug Administration (FDA) in August 2005.
What's the Problem?
Lawsuits allege that many batches of valsartan, the active ingredient in Diovan, were contaminated with NDMA, a probable human carcinogen (cancer-causing substance), between 2012 and 2018. Hundreds of Valsartan products made in China have been recalled. This is the same carcinogen that is currently the subject of Zantac lawsuits.
Diovan Side Effects
Our lawyers are investigating potential lawsuits for people who were diagnosed with the following serious side effects after taking Diovan:
- Stomach cancer
- Small intestine cancer
- Gastric cancer
- Colorectal cancer
- Esophageal cancer
- Prostate cancer (patient must be under the age of 65 at time of diagnosis)
- Liver damage
- Liver cancer
- Liver tumors
- Blood cancer / Leukemia
- Bladder cancer
- Pancreatic cancer
- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Heart failure
- Congestive heart failure
Status of Diovan Lawsuits
A panel of federal judges has combined at least 10 valsartan lawsuits from around the country into a multidistrict litigation (MDL) in New Jersey. The panel identified at least 30 other related lawsuits that could potentially join the MDL. Lawsuits named 20 valsartan manufacturers and other companies as defendants.
As of July 2019, there were 88 lawsuits in the litigation. No trial dates have been set, and there have been no settlements or verdicts.
See all related dangerous drug lawsuits our lawyers have taken on.
What are Diovan Lawsuits Alleging?
The first 10 cases combined in the MDL were consumer class action lawsuits seeking reimbursement for people who had bought contaminated valsartan for as long as 6 years. However, the panel also identified 17 individual personal injury lawsuits alleging that valsartan caused cancer or liver damage. It opened the litigation to personal injury cases as well.
Because it is so widely used, there is the potential for thousands of valsartan lawsuits to be filed before any of the cases go to trial. Bloomberg reported in April 2019 that an attorney handling valsartan lawsuits told judges attending a conference in New Jersey that he expected “approximately 2,000” personal injury lawsuits over the drugs within two years.
Do I Qualify to File a Claim?
It may not be too late to bring a 2022 Diovan lawsuit. Our law firm is currently accepting cases that meet the following criteria:
- The patient took Diovan during the period 2014 or later, and
- After at least one year since starting the drug – and after taking it for at least 30 days – the patient was diagnosed with cancer.
Get a Free Diovan Lawsuit Evaluation With Our Lawyers
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Diovan lawsuits. We are handling individual personal injury litigation nationwide from Diovan patients and currently accepting new Diovan cases in all 50 states.
Again, if you or a loved one got cancer after taking Diovan, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.